DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) – Investment analysts at Barrington Research dropped their FY2022 earnings estimates for shares of DENTSPLY SIRONA in a report released on Tuesday, November 15th. Barrington Research analyst M. Petusky now expects that the medical instruments supplier will post earnings of $1.95 per share for the year, down from their previous forecast of $2.45. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.95 per share. Barrington Research also issued estimates for DENTSPLY SIRONA’s Q4 2022 earnings at $0.32 EPS, Q1 2023 earnings at $0.32 EPS, Q3 2023 earnings at $0.45 EPS, Q4 2023 earnings at $0.48 EPS, FY2023 earnings at $1.80 EPS and FY2024 earnings at $2.00 EPS.
XRAY has been the topic of several other reports. Piper Sandler decreased their target price on shares of DENTSPLY SIRONA from $38.00 to $29.00 in a report on Monday. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA to $32.00 in a report on Thursday. StockNews.com started coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. Evercore ISI upped their price target on shares of DENTSPLY SIRONA to $34.00 in a report on Thursday. Finally, UBS Group reduced their price objective on shares of DENTSPLY SIRONA to $35.00 in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $40.70.
DENTSPLY SIRONA Price Performance
XRAY stock opened at $30.69 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.50 and a debt-to-equity ratio of 0.48. DENTSPLY SIRONA has a 12 month low of $26.48 and a 12 month high of $58.70. The firm has a market cap of $6.60 billion, a P/E ratio of 11.46, a P/E/G ratio of 3.98 and a beta of 0.95. The company’s 50-day moving average price is $29.97 and its two-hundred day moving average price is $34.25.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last released its earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.18). DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. The firm had revenue of $947.00 million during the quarter, compared to the consensus estimate of $1.01 billion. During the same period in the prior year, the business earned $0.68 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 8.9% compared to the same quarter last year.
Institutional Trading of DENTSPLY SIRONA
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wipfli Financial Advisors LLC bought a new position in shares of DENTSPLY SIRONA in the third quarter worth approximately $27,000. Riverview Trust Co boosted its position in shares of DENTSPLY SIRONA by 185.6% in the third quarter. Riverview Trust Co now owns 991 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 644 shares during the period. SRS Capital Advisors Inc. bought a new position in shares of DENTSPLY SIRONA in the third quarter worth approximately $28,000. Ellevest Inc. boosted its position in shares of DENTSPLY SIRONA by 281.2% during the third quarter. Ellevest Inc. now owns 1,216 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 897 shares during the last quarter. Finally, SJS Investment Consulting Inc. bought a new position in shares of DENTSPLY SIRONA during the third quarter worth $35,000. 96.00% of the stock is owned by hedge funds and other institutional investors.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to firstname.lastname@example.org.
Before you consider DENTSPLY SIRONA, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and DENTSPLY SIRONA wasn’t on the list.
While DENTSPLY SIRONA currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.